[CNP_S9] Symposium9
Pregnancy and autism spectrum disorder

[CNP-S9-4] Brain malformation and its improvement pharmacotherapy in an autism spectrum disorder mouse model induced by prenatal exposure to valproic acid

^○Kazuhiro TAKUMA^{1, 2, 3}, Yuta HARA^{3, 4, 5}, Yukio AGO^{3, 4, 6}, Hitoshi HASHIMOTO^{2, 4, 7, 8}, Takanobu NAKAZAWA^{1, 4}, Toshio MATSUDA³ (1. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Suita, Japan, 2. United Graduate School of Child Development, Osaka University, Osaka, Japan, 3. Laboratory of Medicinal Pharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 4. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 5. Cell Biology Laboratory, Faculty of Pharmacy, Kindai University, Osaka, Japan, 6. Laboratory of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 7. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 8. Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan)